|
| 35868984 | Splenic Size and Volume Measurements in Patients with Chronic Lymphocytic Leukemia. | Acad Radiol | 2023 |
| 37620051 | Ethical Considerations for Artificial Intelligence in Medical Imaging: Deployment and Governance. | J Nucl Med | 2023 |
| 37498830 | CT radiomics for differentiating fat poor angiomyolipoma from clear cell renal cell carcinoma: Systematic review and meta-analysis. | PLoS One | 2023 |
| 37672849 | Virtual monoenergetic imaging in photon-counting CT of the head and neck. | Clin Imaging | 2023 |
| 37218945 | Comparison of CT and Dixon MR Abdominal Adipose Tissue Quantification Using a Unified Computer-Assisted Software Framework. | Tomography | 2023 |
| 37384546 | Complications after Nephron-sparing Interventions for Renal Tumors: Imaging Findings and Management. | Radiographics | 2023 |
| 36789136 | Automatic segmentation of clear cell renal cell tumors, kidney, and cysts in patients with von Hippel-Lindau syndrome using U-net architecture on magnetic resonance images. | ArXiv | 2023 |
| 36648999 | A Combined Region- and Pixel-Based Deep Learning Approach for Quantifying Abdominal Adipose Tissue in Adolescents Using Dixon Magnetic Resonance Imaging. | Tomography | 2023 |
| 36459898 | CT radiomics for differentiating oncocytoma from renal cell carcinomas: Systematic review and meta-analysis. | Clin Imaging | 2023 |
| 36207629 | Role of ultra-high b-value DWI in the imaging of hereditary leiomyomatosis and renal cell carcinoma (HLRCC). | Abdom Radiol (NY) | 2023 |
| 34809860 | Trustworthy Artificial Intelligence in Medical Imaging. | PET Clin | 2022 |
| 35869307 | An MRI-based radiomics model to predict clear cell renal cell carcinoma growth rate classes in patients with von Hippel-Lindau syndrome. | Abdom Radiol (NY) | 2022 |
| 35159060 | The Next Paradigm Shift in the Management of Clear Cell Renal Cancer: Radiogenomics-Definition, Current Advances, and Future Directions. | Cancers (Basel) | 2022 |
| 35283807 | Parathyroid Imaging: Past, Present, and Future. | Front Endocrinol (Lausanne) | 2022 |
| 34809862 | Artificial Intelligence in Medical Imaging and its Impact on the Rare Disease Community: Threats, Challenges and Opportunities. | PET Clin | 2022 |
| 32855051 | Comparison of Low Dose Performance of Photon-Counting and Energy Integrating CT. | Acad Radiol | 2021 |
| 33874734 | CT Evaluation of Lymph Nodes That Merge or Split during the Course of a Clinical Trial: Limitations of RECIST 1.1. | Radiol Imaging Cancer | 2021 |
| 33728278 | Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model. | J Hepatocell Carcinoma | 2021 |
| 34898541 | Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma. | Curr Oncol | 2021 |
| 34778782 | Evaluation of Coronary Plaques and Stents with Conventional and Photon-counting CT: Benefits of High-Resolution Photon-counting CT. | Radiol Cardiothorac Imaging | 2021 |
| 34250492 | T2-weighted Lung Imaging Using a 0.55-T MRI System. | Radiol Cardiothorac Imaging | 2021 |
| 34250326 | A Clinically Driven Task-Based Comparison of Photon Counting and Conventional Energy Integrating CT for Soft Tissue, Vascular, and High-Resolution Tasks. | IEEE Trans Radiat Plasma Med Sci | 2021 |
| 34171743 | A deep-learning based artificial intelligence (AI) approach for differentiation of clear cell renal cell carcinoma from oncocytoma on multi-phasic MRI. | Clin Imaging | 2021 |
| 33399350 | Review of Technical Advancements and Clinical Applications of Photon-counting Computed Tomography in Imaging of the Thorax. | J Thorac Imaging | 2021 |
| 32562921 | Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome: Spectrum of imaging findings. | Clin Imaging | 2020 |
| 32107125 | Transarterial Chemoembolization in a Woodchuck Model of Hepatocellular Carcinoma. | J Vasc Interv Radiol | 2020 |
| 32888545 | Reinventing Molecular Imaging with Total-Body PET, Part II: Clinical Applications. | PET Clin | 2020 |
| 32798209 | Reinventing Molecular Imaging with Total-Body PET, Part I: Technical Revolution in Evolution. | PET Clin | 2020 |
| 32796848 | Artificial intelligence for the detection of COVID-19 pneumonia on chest CT using multinational datasets. | Nat Commun | 2020 |
| 32758463 | The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis. | Lancet Oncol | 2020 |
| 32421466 | Clear Cell Renal Cell Carcinoma Growth Correlates with Baseline Diffusion-weighted MRI in Von Hippel-Lindau Disease. | Radiology | 2020 |
| 31573398 | Opportunities in Interventional and Diagnostic Imaging by Using High-Performance Low-Field-Strength MRI. | Radiology | 2019 |
| 33458294 | Automatic segmentation of cardiac structures for breast cancer radiotherapy. | Phys Imaging Radiat Oncol | 2019 |
| 30766960 | Development of Hepatic Steatosis After Chemotherapy for Non-Hodgkin Lymphoma. | Hepatol Commun | 2018 |
| 28753389 | Feasibility of Dose-reduced Chest CT with Photon-counting Detectors: Initial Results in Humans. | Radiology | 2017 |
| 26840654 | Abdominal Imaging with Contrast-enhanced Photon-counting CT: First Human Experience. | Radiology | 2016 |
| 27192671 | Danazol Treatment for Telomere Diseases. | N Engl J Med | 2016 |
| 27133589 | High pitch third generation dual-source CT: Coronary and cardiac visualization on routine chest CT. | J Cardiovasc Comput Tomogr | 2016 |
| 23535191 | Assessing splenomegaly: automated volumetric analysis of the spleen. | Acad Radiol | 2013 |
| 23449957 | Automated detection of sclerotic metastases in the thoracolumbar spine at CT. | Radiology | 2013 |
| 22361033 | Assessing hepatomegaly: automated volumetric analysis of the liver. | Acad Radiol | 2012 |
| 22068656 | A pilot study of MUC-1/CEA/TRICOM poxviral-based vaccine in patients with metastatic breast and ovarian cancer. | Clin Cancer Res | 2011 |
| 19890632 | Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer. | Cancer Immunol Immunother | 2010 |
| 20308663 | Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer. | J Clin Oncol | 2010 |
| 19154507 | Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer. | BJU Int | 2009 |
| 18172272 | A phase II clinical trial of sorafenib in androgen-independent prostate cancer. | Clin Cancer Res | 2008 |
| 17155971 | Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone. | BJU Int | 2007 |
| 17707059 | Clinical safety of a viral vector based prostate cancer vaccine strategy. | J Urol | 2007 |
| 17278070 | The incidence and natural history of osteonecrosis in HIV-infected adults. | Clin Infect Dis | 2007 |
| 17437439 | Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer. | BJU Int | 2007 |